B-093 Establishing measurement uncertainty for tumor markers: impact of analytical variation in quality control material vs patient serum matrix
The College of American Pathologists (CAP) recommends estimating measurement uncertainty (MU) during validation (typically by analyzing replicates of quality control [QC] material over 5 days); and re-evaluating MU estimates in response to a clinical inquiry (typically by a top-down approach using extended length...